Have a personal or library account? Click to login

The canonical FGF-FGFR signaling system at the molecular level

Open Access
|Jan 2022

References

  1. Itoh N., Ornitz D.M.: Evolution of the Fgf and Fgfr gene families. Trends Genet., 2004; 20: 563-569
  2. Ogawa K., Kobayashi C., Hayashi T., Orii H., Watanabe K., Agata K.: Planarian fibroblast growth factor receptor homologs expressed in stem cells and cephalic ganglions. Dev. Growth Differ., 2002; 44: 191-204
  3. Itoh N., Ornitz D.M.: Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease. J. Biochem., 2011; 149: 121-130
  4. Itoh N., Ornitz D.M.: Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn., 2008; 237: 18-27
  5. Mason I.: Initiation to end point: The multiple roles of fibroblast growth factors in neural development. Nat. Rev. Neurosci., 2007; 8: 583-596
  6. Pourquié O.: Vertebrate segmentation: From cyclic gene networks to scoliosis. Cell, 2011; 145: 650-663
  7. Thisse B., Thisse C.: Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol., 2005; 287: 390-402
  8. Tulin S., Stathopoulos A.: Extending the family table: Insights from beyond vertebrates into the regulation of embryonic development by FGFs. Birth Defects Res C Embryo Today, 2010; 90: 214-227
  9. Dailey L., Ambrosetti D., Mansukhani A., Basilico C.: Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev., 2005; 16: 233-247
  10. Beenken A., Mohammadi M.: The FGF family: Biology, pathophysiology and therapy. Nat. Rev. Drug Discov., 2009; 8: 235-253
  11. Ornitz D.M., Itoh N.: The fibroblast growth factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol., 2015; 4: 215-266
  12. Ornitz D.M., Itoh N.: Fibroblast growth factors. Genome Biol., 2001; 2: 3005
  13. Powers C.J., McLeskey S.W., Wellstein A.: Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer, 2000; 7: 165-197
  14. Blaber M., DiSalvo J., Thomas K.A.: X-ray crystal structure of human acidic fibroblast growth factor. Biochemistry, 1996; 35: 2086-2094
  15. Murzin A.G., Lesk A.M., Chothia C.: β-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1β and 1α and fibroblast growth factors. J. Mol. Biol., 1992; 223: 531-543
  16. Gosavi S., Whitford P.C., Jennings P.A., Onuchic J.N.: Extracting function from a beta-trefoil folding motif. Proc. Natl. Acad. Sci. USA, 2008; 105: 10384-10389
  17. Laestander C., Engström W.: Role of fibroblast growth factors in elicitation of cell responses. Cell Prolif., 2014; 47: 3-11
  18. Nickel W., Seedorf M.: Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol., 2008; 24: 287-308
  19. Prudovsky I., Tarantini F., Landriscina M., Neivandt D., Soldi R., Kirov A., Small D., Kathir K.M., Rajalingam D., Kumar T.K.: Secretion without Golgi. J. Cell. Biochem., 2008; 103: 1327-1343
  20. Ornitz D.M.: FGFs, heparan sulfate and FGFRs: Complex interactions essential for development. Bioessays, 2000; 22: 108-112
  21. Makarenkova H.P., Hoffman M.P., Beenken A., Eliseenkova A.V., Meech R., Tsau C., Patel V.N., Lang R.A., Mohammadi M.: Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal., 2009; 2: ra55
  22. Pellegrini L.: Role of heparan sulfate in fibroblast growth factor signalling: A structural view. Curr. Opin. Struct. Biol., 2001; 11: 629-634
  23. Zhang F., Zhang Z., Lin X., Beenken A., Eliseenkova A.V., Mohammadi M., Linhardt R.J.: Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry, 2009; 48: 8379-8386
  24. Itoh N.: Hormone-like (endocrine) FGFs: Their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res., 2010; 342: 1-11
  25. Itoh N., Ohta H., Konishi M.: Endocrine FGFs: Evolution, physiology, pathophysiology, and pharmacotherapy. Front. Endocrinol., 2015; 6: 154
  26. Medici D., Razzaque M.S., Deluca S., Rector T.L., Hou B., Kang K., Goetz R., Mohammadi M., Kuro-o M., Olsen B.R., Lanske B.: FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J. Cell Biol., 2008; 182: 459-465
  27. Goetz R., Dover K., Laezza F., Shtraizent N., Huang X., Tchetchik D., Eliseenkova A.V., Xu C.F., Neubert T.A., Ornitz D.M., Goldfarb M., Mohammadi M.: Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J. Biol. Chem., 2009; 284: 17883-17896
  28. Olsen S.K., Garbi M., Zampieri N., Eliseenkova A.V., Ornitz D.M., Goldfarb M., Mohammadi M.: Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J. Biol. Chem., 2003; 278: 34226-34236
  29. Goldfarb M., Schoorlemmer J., Williams A., Diwakar S., Wang Q., Huang X., Giza J., Tchetchik D., Kelley K., Vega A., Matthews G., Rossi P., Ornitz D.M., D’Angelo E.: Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron, 2007; 55: 449-463
  30. Lou J.Y., Laezza F., Gerber B.R., Xiao M., Yamada K.A., Hartmann H., Craig A.M., Nerbonne J.M., Ornitz D.M.: Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J. Physiol., 2005; 569: 179-193
  31. Schoorlemmer J., Goldfarb M.: Fibroblast growth factor homologous factors are intracellular signaling proteins. Curr. Biol., 2001; 11: 793-797
  32. Bruns A.F., van Bergeijk J., Lorbeer C., Nölle A., Jungnickel J., Grothe C., Claus P.: Fibroblast growth factor-2 regulates the stability of nuclear bodies. Proc. Natl. Acad. Sci. USA, 2009; 106: 12747-12752
  33. Kiefer P., Acland P., Pappin D., Peters G., Dickson C.: Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J., 1994; 13: 4126-4136
  34. Kostas M., Lampart A., Bober J., Wiedlocha A., Tomala J., Krowarsch D., Otlewski J., Zakrzewska M.: Translocation of exogenous FGF1 and FGF2 protects the cell against apoptosis independently of receptor activation. J. Mol. Biol., 2018; 430: 4087-4101
  35. Sørensen V., Nilsen T., Wiedłocha A.: Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays, 2006; 28: 504-514
  36. Sørensen V., Zhen Y., Zakrzewska M., Haugsten E.M., Wälchli S., Nilsen T., Olsnes S., Wiedlocha A.: Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus. Mol. Cell. Biol., 2008; 28: 4129-4141
  37. Sluzalska K.D., Slawski J., Sochacka M., Lampart A., Otlewski J., Zakrzewska M.: Intracellular partners of fibroblast growth factors 1 and 2 - implications for functions. Cytokine Growth Factor Rev., 2021; 57: 93-111
  38. Eswarakumar V.P., Lax I., Schlessinger J.: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev., 2005; 16: 139-149
  39. Lemmon M.A., Schlessinger J.: Cell signaling by receptor tyrosine kinases. Cell, 2010; 141: 1117-1134
  40. Sarrazin S., Lamanna W.C., Esko J.D.: Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol., 2011; 3: a004952
  41. Harmer N.J.: Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem. Soc. Trans., 2006; 34: 442-445
  42. Johnson D.E., Williams L.T.: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 1993; 60: 1-41
  43. Scotet E., Houssaint E.: The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific. Biochim. Biophys. Acta, 1995; 1264: 238-242
  44. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L.: Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature, 2000; 407: 1029-1034
  45. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., Eliseenkova A.V., Yeh B.K., Yayon A., Linhardt R.J., Mohammadi M.: Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell, 2000; 6: 743-750
  46. Mohammadi M., Olsen S.K., Goetz R.: A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol., 2005; 15: 506-516
  47. Paul M.D., Hristova K.: The RTK interactome: Overview and perspective on RTK heterointeractions. Chem. Rev., 2019; 119: 5881-5921
  48. Sarabipour S., Hristova K.: Mechanism of FGF receptor dimerization and activation. Nat. Commun., 2016; 7: 10262
  49. Brown A., Robinson C.J., Gallagher J.T., Blundell T.L.: Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes. Biophys. J., 2013; 104: 1720-1730
  50. Pomin V.H.: Paradigms in the structural biology of the mitogenic ternary complex FGF:FGFR:heparin. Biochimie, 2016; 127: 214-226
  51. Patel V.N., Likar K.M., Zisman-Rozen S., Cowherd S.N., Lassiter K.S., Sher I., Yates E.A., Turnbull J.E., Ron D., Hoffman M.P.: Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation. J. Biol. Chem., 2008; 283: 9308-9317
  52. Goetz R., Mohammadi M.: Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol., 2013; 14: 166-180
  53. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J.: Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol., 1996; 16: 977-989
  54. Mohammadi M., Honegger A.M., Rotin D., Fischer R., Bellot F., Li W., Dionne C.A., Jaye M., Rubinstein M., Schlessinger J.: A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol. Cell. Biol., 1991; 11: 5068-5078
  55. Furdui C.M., Lew E.D., Schlessinger J., Anderson K.S.: Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell, 2006; 21: 711-717
  56. Hadari Y.R., Kouhara H., Lax I., Schlessinger J.: Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol., 1998; 18: 3966-3973
  57. Kouhara H., Hadari Y.R., Spivak-Kroizman T., Schilling J., Bar-Sagi D., Lax I., Schlessinger J.: A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell, 1997; 89: 693-702
  58. Lanner F., Rossant J.: The role of FGF/Erk signaling in pluripotent cells. Development, 2010; 137: 3351-3360
  59. Lamothe B., Yamada M., Schaeper U., Birchmeier W., Lax I., Schlessinger J.: The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol. Cell. Biol., 2004; 24: 5657-5666
  60. Manning B.D., Cantley L.C.: AKT/PKB signaling: Navigating downstream. Cell, 2007; 129: 1261-1274
  61. Hung C.M., Garcia-Haro L., Sparks C.A., Guertin D.A.: mTOR-dependent cell survival mechanisms. Cold Spring Harb. Perspect. Biol., 2012; 4: a008771
  62. Dudka A.A., Sweet S.M., Heath J.K.: Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. Cancer Res., 2010; 70: 3391-3401
  63. Cross M.J., Lu L., Magnusson P., Nyqvist D., Holmqvist K., Welsh M., Claesson-Welsh L.: The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol. Biol. Cell, 2002; 13: 2881-2893
  64. Larsson H., Klint P., Landgren E., Claesson-Welsh L.: Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem., 1999; 274: 25726-25734
  65. Seo J.H., Suenaga A., Hatakeyama M., Taiji M., Imamoto A.: Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Mol. Cell. Biol., 2009; 29: 3076-3087
  66. Zhang Y., Lin Y., Bowles C., Wang F.: Direct cell cycle regulation by the fibroblast growth factor receptor (FGFR) kinase through phosphorylation-dependent release of Cks1 from FGFR substrate 2. J. Biol. Chem., 2004; 279: 55348-55354
  67. Hatai M., Hashi H., Mogi A., Soga H., Yokota J., Yaoi Y.: Stimulation of tyrosine- and serine-phosphorylation of focal adhesion kinase in mouse 3T3 cells by fibronectin and fibroblast growth factor. FEBS Lett., 1994; 350: 113-116
  68. Burrus L.W., Zuber M.E., Lueddecke B.A., Olwin B.B.: Identification of a cysteine-rich receptor for fibroblast growth factors. Mol. Cell. Biol., 1992; 12: 5600-5609
  69. Köhl R., Antoine M., Olwin B.B., Dickson C., Kiefer P.: Cysteine-rich fibroblast growth factor receptor alters secretion and intracellular routing of fibroblast growth factor 3. J. Biol. Chem., 2000; 275: 15741-15748
  70. Miyaoka Y., Tanaka M., Imamura T., Takada S., Miyajima A.: A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk). Development, 2010; 137: 159-167
  71. Klein S., Bikfalvi A., Birkenmeier T.M., Giancotti F.G., Rifkin D.B.: Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J. Biol. Chem., 1996; 271: 22583-22590
  72. Tanghetti E., Ria R., Dell’Era P., Urbinati C., Rusnati M., Ennas M.G., Presta M.: Biological activity of substrate-bound basic fibroblast growth factor (FGF2): Recruitment of FGF receptor-1 in endothelial cell adhesion contacts. Oncogene, 2002; 21: 3889-3897
  73. Flajolet M., Wang Z., Futter M., Shen W., Nuangchamnong N., Bendor J., Wallach I., Nairn A.C., Surmeier D.J., Greengard P.: FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci., 2008; 11: 1402-1409
  74. Yokote H., Fujita K., Jing X., Sawada T., Liang S., Yao L., Yan X., Zhang Y., Schlessinger J., Sakaguchi K.: Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc. Natl. Acad. Sci. USA, 2005; 102: 18866-18871
  75. Kiselyov V.V., Skladchikova G., Hinsby A.M., Jensen P.H., Kulahin N., Soroka V., Pedersen N., Tsetlin V., Poulsen F.M., Berezin V., Bock E.: Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure, 2003; 11: 691-701
  76. Kulahin N., Li S., Hinsby A., Kiselyov V., Berezin V., Bock E.: Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor. Mol. Cell. Neurosci., 2008; 37: 528-536
  77. Murakami M., Elfenbein A., Simons M.: Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc. Res., 2008; 78: 223-231
  78. Suyama K., Shapiro I., Guttman M., Hazan R.B.: A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell, 2002; 2: 301-314
  79. Francavilla C., Cattaneo P., Berezin V., Bock E., Ami D., de Marco A., Christofori G., Cavallaro U.: The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J. Cell Biol., 2009; 187: 1101-1116
  80. Zamai M., Trullo A., Giordano M., Corti V., Cuesta E.A., Francavilla C., Cavallaro U., Caiolfa V.R.: Number and brightness analysis reveals that NCAM and FGF2 elicit different assembly and dynamics of FGFR1 in live cells. J. Cell Sci., 2019; 132: jcs220624
  81. Cavallaro U., Niedermeyer J., Fuxa M., Christofori G.: N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol., 2001; 3: 650-657
  82. Dikic I., Giordano S.: Negative receptor signalling. Curr. Opin. Cell Biol., 2003; 15: 128-135
  83. Yim D.G., Ghosh S., Guy G.R., Virshup D.M.: Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling. Oncogene, 2015; 34: 474-484
  84. Kostas M., Haugsten E.M., Zhen Y., Sørensen V., Szybowska P., Fiorito E., Lorenz S., Jones N., de Souza G.A., Wiedlocha A., Wesche J.: Protein tyrosine phosphatase receptor type G (PT-PRG) controls fibroblast growth factor receptor (FGFR) 1 activity and influences sensitivity to FGFR kinase inhibitors. Mol. Cell. Proteomics, 2018; 17: 850-870
  85. Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C., Boschert U., Arkinstall S.: Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science, 1998; 280: 1262-1265
  86. Turner N., Grose R.: Fibroblast growth factor signalling: From development to cancer. Nat. Rev. Cancer, 2010; 10: 116-129
  87. Szybowska P., Kostas M., Wesche J., Haugsten E., M., Wiedlocha A.: Negative regulation of FGFR (Fibroblast Growth Factor Receptor) signaling. Cells, 2021; 10;1342
Language: English
Page range: 711 - 719
Submitted on: Oct 16, 2020
Accepted on: Feb 24, 2021
Published on: Jan 17, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Patrycja Szybowska, Ellen Margrethe Haugsten, Antoni Wiedlocha, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.